Sunshine Biopharma, Inc.
SBFM
$1.40
-$0.02-1.41%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.31M | 8.20M | 9.69M | 12.21M | 11.51M |
| Total Receivables | 3.59M | 3.45M | 3.87M | 3.22M | 3.97M |
| Inventory | 13.02M | 11.86M | 11.28M | 9.82M | 8.49M |
| Prepaid Expenses | 939.40K | 983.50K | 1.13M | 735.80K | 1.78M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 27.85M | 24.48M | 25.97M | 25.98M | 25.75M |
|
|
|||||
| Total Current Assets | 27.85M | 24.48M | 25.97M | 25.98M | 25.75M |
| Net Property, Plant & Equipment | 1.53M | 1.42M | 1.48M | 1.13M | 1.11M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 2.49M | 3.19M | 3.02M | 2.94M | 2.45M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 92.20K | 92.20K | 92.20K | -- | -- |
| Total Assets | 31.97M | 29.19M | 30.56M | 30.06M | 29.30M |
|
|
|||||
| Total Accounts Payable | 4.80M | 5.02M | 5.54M | 4.16M | 4.93M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 222.50K | 214.00K | 207.80K | 116.30K | 114.50K |
| Total Finance Division Other Current Liabilities | 554.00K | 523.90K | 564.10K | 255.00K | 255.00K |
| Total Other Current Liabilities | 554.00K | 523.90K | 564.10K | 255.00K | 255.00K |
| Total Current Liabilities | 5.57M | 5.76M | 6.31M | 4.53M | 5.30M |
|
|
|||||
| Total Current Liabilities | 5.57M | 5.76M | 6.31M | 4.53M | 5.30M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 706.50K | 722.20K | 744.70K | 440.30K | 462.90K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 48.70K | 48.70K |
| Total Liabilities | 6.28M | 6.48M | 7.06M | 5.02M | 5.81M |
|
|
|||||
| Common Stock & APIC | 97.38M | 93.71M | 93.36M | 91.74M | 89.84M |
| Retained Earnings | -71.99M | -70.22M | -69.04M | -66.88M | -65.68M |
| Treasury Stock & Other | 280.80K | -803.80K | -830.00K | 168.60K | -683.10K |
| Total Common Equity | 25.67M | 22.69M | 23.49M | 25.03M | 23.48M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | 13.00K | 13.00K | 13.00K | 13.00K | 13.00K |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 13.00K | 13.00K | 13.00K | 13.00K | 13.00K |
|
|
|||||
| Total Common Equity | 25.67M | 22.69M | 23.49M | 25.03M | 23.48M |
| Total Preferred Equity | 13.00K | 13.00K | 13.00K | 13.00K | 13.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 25.68M | 22.70M | 23.50M | 25.04M | 23.49M |
|
|
|||||